Interim PET for prognosis in adults with Hodgkin lymphoma: a prognostic factor exemplar review
Sign Up to like & getrecommendations! Published in 2017 at "Cochrane Database of Systematic Reviews"
DOI: 10.1002/14651858.cd012643
Abstract: This is a protocol for a Cochrane Review (Prognosis). The objectives are as follows: Primary objective The objective of this systematic review is to identify all studies evaluating interim PET scan results as a prognostic… read more here.
Keywords: pet prognosis; prognostic factor; review; interim pet ... See more keywords
Baseline and interim PET‐based outcome prediction in peripheral T‐cell lymphoma: A subgroup analysis of the PETAL trial
Sign Up to like & getrecommendations! Published in 2020 at "Hematological Oncology"
DOI: 10.1002/hon.2697
Abstract: The prospective randomized Positron Emission Tomography (PET)‐Guided Therapy of Aggressive Non‐Hodgkin Lymphomas (PETAL) trial was designed to test the ability of interim PET (iPET) to direct therapy. As reported previously, outcome remained unaffected by iPET‐based… read more here.
Keywords: ipet response; lymphoma; interim pet; ipet ... See more keywords
Enhancing prognostic accuracy in PMBCL: semiquantitative analysis of interim PET/CT scans
Sign Up to like & getrecommendations! Published in 2025 at "Scientific Reports"
DOI: 10.1038/s41598-025-18649-9
Abstract: Primary mediastinal large B-cell lymphoma (PMBCL) is a rare, aggressive lymphoma affecting young adults. Interim PET/CT (iPET/CT) scans are used to assess treatment response, but the positive predictive value of standard Deauville score remains limited.… read more here.
Keywords: analysis; pet scans; accuracy; pmbcl ... See more keywords
The clinical value of interim PET/computed tomography scanning in patients with classical Hodgkin's lymphoma and its influence on prognosis in Duhok Province, Kurdistan Region - Northern Iraq.
Sign Up to like & getrecommendations! Published in 2025 at "Nuclear medicine communications"
DOI: 10.1097/mnm.0000000000002065
Abstract: Background Classical Hodgkin’s lymphoma (cHL) is a largely curable cancer, although a percentage of patients experience recurrence or treatment failure. Interim PET(iPET)/computed tomography (CT) scanning after 2–4 rounds of adriamycin, bleomycin, vinblastine, and dacarbazine chemotherapy… read more here.
Keywords: classical hodgkin; treatment; response; duhok ... See more keywords
18F-FDG PET/CT in Tuberculosis: Can Interim PET/CT Predict the Clinical Outcome of the Patients?
Sign Up to like & getrecommendations! Published in 2020 at "Clinical Nuclear Medicine"
DOI: 10.1097/rlu.0000000000002968
Abstract: PURPOSE OF THE REPORT Tuberculosis (TB) is a major health problem. Activated macrophages in TB lesions show high metabolic activity and can be assessed using F-FDG PET/CT. This retroprospective study was done to evaluate the… read more here.
Keywords: outcome patients; response; clinical outcome; fdg pet ... See more keywords
Risk Stratification Integrating Deauville Score on Interim PET-CT Scan and Baseline International Prognostic Index in Diffuse Large B-Cell Lymphoma Patients
Sign Up to like & getrecommendations! Published in 2018 at "Blood"
DOI: 10.1182/blood-2018-99-114365
Abstract: Background Interim 18F-fluorodeoxyglucose positron emission tomography-computed tomography (PET-CT) scan may predict outcomes in patients with diffuse large B-cell lymphoma (DLBCL). However, overall accuracy in predicting treatment outcomes on adopting 5-point Deauville score (DS) was considerably… read more here.
Keywords: medicine; risk; ipi; interim pet ... See more keywords
Real-World Adherence to National Comprehensive Cancer Network (NCCN) Guidelines Regarding the Usage of PET/CT and Reported Deauville Scores in Advanced Stage Classical Hodgkin Lymphoma: A Community Oncology Practice Perspective
Sign Up to like & getrecommendations! Published in 2020 at "Blood"
DOI: 10.1182/blood-2020-140698
Abstract: Introduction: Current National Comprehensive Cancer Network (NCCN) guidelines recommend one of three frontline (1L) regimens to treat stage III or IV classical Hodgkin Lymphoma (cHL): doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD), brentuximab vedotin, doxorubicin, vinblastine,… read more here.
Keywords: deauville scores; genetics; treatment; interim pet ... See more keywords
Classical Hodgkin Lymphoma; Real-World Observations from Physicians, Patients, and Caregivers on the Disease and Its Treatment (CONNECT): Observations of Physicians on Treatment and Interim PET-Adapted Regimens
Sign Up to like & getrecommendations! Published in 2021 at "Blood"
DOI: 10.1182/blood-2021-151143
Abstract: Background Current NCCN guidelines recommend 1 of 3 first-line (1L) regimens for stage III or IV classical Hodgkin lymphoma (cHL): ABVD (doxorubicin, bleomycin, vinblastine, dacarbazine), A+AVD (brentuximab vedotin, doxorubicin, vinblastine, dacarbazine), or escalated BEACOPP (bleomycin,… read more here.
Keywords: pet; interim pet; pet scans; treatment ... See more keywords
Interim PET-Adapted De-Escalation Chemotherapy Regimen for Advanced Stage Classical Hodgkin Lymphoma Using Brentuximab Vedotin, Pembrolizumab, Doxorubicin, and Dacarbazine: Phase 2 Safety and Efficacy Study
Sign Up to like & getrecommendations! Published in 2024 at "Blood"
DOI: 10.1182/blood-2024-212005
Abstract: Background: Brentuximab vedotin (Bv), Nivolumab (N) and Pembrolizumab (P) have revolutionized the management of advanced stage classical Hodgkin Lymphoma (AS cHL). Significant improvements in both safety and efficacy have been observed with the Echelon-1 (E1)… read more here.
Keywords: pembrolizumab; hodgkin; pet adapted; safety ... See more keywords
Brentuximab vedotin (Bv)+AVD efficacy is influenced by interim PET, age, ECOG performance status and CIRS-g in previously untreated patients with stage IV classical Hodgkin lymphoma: An Italian real-life multicentric study
Sign Up to like & getrecommendations! Published in 2025 at "Blood"
DOI: 10.1182/blood-2025-5402
Abstract: Introduction: In Italy, Brentuximab vedotin (Bv) with AVD (adriamycin, vinblastine, dacarbazine) received approval for the first-line treatment of stage IV classical Hodgkin lymphoma (cHL) in September 2021, with no upper age restriction. Considering the upcoming… read more here.
Keywords: age; avd abvd; group; age years ... See more keywords
Prognostic role of interim PET in follicular lymphoma: a post hoc study of FOLL12 trial by Fondazione Italiana Linfomi
Sign Up to like & getrecommendations! Published in 2025 at "Blood Advances"
DOI: 10.1182/bloodadvances.2024014790
Abstract: Key Points • Achievement of CMR after 4 cycles of first-line ICT is associated with improved outcomes in FL patients.• The prognostic role of early metabolic response is independent from the type of induction therapy… read more here.
Keywords: role; follicular lymphoma; prognostic role; role interim ... See more keywords